DEA MATE Curriculum-Part 2

Modules 5-10 & Independent Reading Post-Test and Evaluation

Participant demographics:

Question Title

* 1. Full Name:

Question Title

* 2. Please indicate credentials

Question Title

* 3. License number (Florida providers will be reported to CE Broker):

Question Title

* 4. Please provide email address for CME certificate delivery.

Question Title

* 5. How many credit(s) are you claiming:

1.00

2.00

3.00

maximum (4.0)

Other (please specify)

DEA MATE Curriculum Part 2 Post-Test (a passing score of 90% is required).

Question Title

* 6. The term "co-occurring" may include which of the following?

Initial addiction issues then subsequent mental health diagnosis

Pre-existing mental health issues then subsequent addiction issues

Initial addiction then subsequent medical diagnoses

Pre-existing medical issues then subsequent addiction diagnosis

all are possible and are seen as "co-occurring"

Question Title

* 7. Per studies published in JAMA Psychiatry and Lancet Psychiatry, cannabis use disorder is associated with increased risk for additional mental health diagnoses.

True

False

Question Title

* 8. Substance Use Disorder and Mental Health diagnoses impairing an individual's ability to function and work qualifies under Family and Medical Leave Act.

True

False

Question Title

* 9. Most recent cases of Fentanyl-related overdose are linked to illicitly procured pharmaceutical Fentanyl.

True

False

Question Title

* 10. Xylazine is a tranquilizer for animals and has been found to be life-threatening if mixed with illicit drugs, such as Cocaine, Heroin, and Fentanyl.

True

False

Question Title

* 11. Patients at risk for opioid overdose include which of the following:

have recently been released from incarceration and have a history of opioid use disorder or opioid misuse

anyone who uses opioid for long-term chronic pain management

have been discharged from emergency medical care following an opioid overdose

have completed opioid detoxification or are abstinent for a period of time

all of the above

Question Title

* 12. Naloxone is not effective in treating overdoses of Benzodiazepines, Barbiturates, Clonidine, Xylazine, GHB, Ketamine, Cocaine, Amphetamines and Methamphetamine.

True

False

Question Title

* 13. Multifaceted approach for patients with substance use disorder and chronic pain include which of the following options?

psychobehavioral, such as medication, treatment of mood/trauma issues, address high risk use of substances or addiction

physical, such as exercise, manual therapies, orthotics, transcutaneous electrical nerve stimulation

procedural, such as acupuncture, nerve blocks, steroid injections, trigger point injections

medication, such as NSAIDS, anticonvulsants, antidepressants, topical agents

all of the above

Question Title

* 14. Buprenorphine pharmacology is a partial agonist at the MU Opioid Receptor, an antagonist at the Kappa Opioid Receptor and an antagonist at the Delta Opioid Receptor making it a viable pain medication for patients with substance use disorder and chronic pain.

True

False

Question Title

* 15. A patient attending 3-4 support group meetings per day for alcohol use disorder or substance use disorder has no better recovery than if they attend 1-2 support group meetings per day.

True

False

Question Title

* 16. Ethyl Glucuronide (ETG) testing is excellent for monitoring alcohol abstinence over 72 hours.

True

False

Question Title

* 17. CFR 42, Part 2-Confidentiality of Substance Use Disorder Patient Records includes tobacco and caffeine use in the Substance Use Disorder definition.

True

False